Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.71 | N/A | -4.96% |
management commentary, guidance changes, and full analysis available with Pro.
| -4.96% |
Tone: Cautiously Optimistic
Management expressed confidence in the company's strategic direction despite the slight EPS miss. They highlighted strong demand in key markets as a positive sign.
We are seeing strong demand in key markets.
Our focus remains on innovation and customer satisfaction.
Agilent Technologies reported an EPS of $0.71, which was slightly below expectations, resulting in a small negative surprise. However, the stock rose by 2.94%, likely driven by positive sentiment around strong demand in key markets. Investors may be encouraged by management's focus on innovation and customer satisfaction despite the earnings miss.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CRINETICS PHARMACEUT
May 13, 2019